Escalon Medical Corp.
ESMC · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.20 | 0.06 | 0.00 | -0.42 |
| FCF Yield | 15,860.30% | -60.86% | 16.79% | -111.88% |
| EV / EBITDA | -3,269.84 | -23.47 | 3.54 | 4.25 |
| Quality | ||||
| ROIC | 5.46% | -4.48% | 16.94% | 1.36% |
| Gross Margin | 45.75% | 42.95% | 45.00% | 43.04% |
| Cash Conversion Ratio | 3.61 | 4.81 | 0.71 | -58.07 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.37% | 3.83% | 5.17% | 4.42% |
| Free Cash Flow Growth | 59,305.57% | -306.57% | 129.65% | -226.60% |
| Safety | ||||
| Net Debt / EBITDA | -3,284.30 | -5.40 | 0.00 | 1.68 |
| Interest Coverage | 0.01 | -5.03 | 22.04 | 1.98 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 4.24 | 4.22 | 3.80 |
| Cash Conversion Cycle | 92,694.75 | 78.37 | 70.40 | 87.99 |